Emerging Technology
Business Wire | September 14, 2023
OPEXUS, formerly known as AINS, LLC, and leader in government process management software, today announces it has attained StateRAMP authorization for eCASE®, a built-for-government case management solution that streamlines workflows and accelerates key government processes.
StateRAMP was established in 2020 to efficiently verify that service providers meet the cloud security standards required to do business with state and local governments. The StateRAMP verification process, built upon the widely accepted National Institute of Standards and Technology (NIST) Special Publication 800-53 framework, and independently audited by a reputable third-party assessment organization (3PAO), ensures the highest level of security and compliance. Achievement of this authorization underscores the company's dedication to supporting state and local governments with cutting-edge technology that enhances productivity, flexibility, and collaboration.
With this certification, OPEXUS will empower state, local, and educational (SLED) agencies to elevate trust in public institutions with dynamic case management and rapid application development technology that was purpose-built for the government. OPEXUS supports public sector human resources teams by providing an umbrella of workforce management tools that include eCASE® EEO/eComplaint and eCASE® ER/LR. The company also offers eCASE® Audit and eCASE® Investigations, case-management tools built specifically for government auditors and investigators.
"State and local government agencies experience many challenges keeping pace with private sector advancements in technology, cyber security, and data security software – from long purchasing timelines to budget constraints, but they cannot compromise on security,” said Howard Langsam, CEO of OPEXUS. “By demonstrating our security qualifications through StateRAMP, we are removing one more barrier to these agencies being able to purchase cloud solutions that meet both their operational and security requirements.”
In 2014, OPEXUS attained FedRAMP authorization at the moderate level for its eCASE®, eCASE® COTS and FOIAXpress® solutions, including Audit, Investigations, Employee & Labor Relations, and EEO Complaints. The company has also achieved Defense Information Systems Agency Impact Level 2 (DISA IL2), FISMA, NIST 800-53 Revision 4, and FIPS certifications.
About OPEXUS
Get government unstuck with OPEXUS. OPEXUS is the leader in FedRAMP-certified government process management software with more than 30 years of experience supporting public institutions. The company brings operational excellence to governments’ middle office so agencies can focus on the critical work of mission delivery. OPEXUS empowers 100,000 government users with exceptional technology experiences and a built-for-government product suite, including solutions for audit, investigations, correspondence, Freedom of Information Act (FOIA) requests, and employee and labor relations. Located in the heart of Washington D.C., OPEXUS works with more than 150 public institutions in the US and Canada.
Read More
Emerging Technology
PR Newswire | August 10, 2023
Bloomberg Government announced today the release of several enhancements geared toward improving how its subscribers monitor and analyze state policy changes. These enhancements allow state-focused policy professionals to easily track and visualize legislation across multiple jurisdictions in all 50 states and the District of Columbia. These new features will be showcased at the National Conference of State Legislatures (NCSL) Legislative Summit, taking place in Indianapolis, Indiana from August 14 to 16.
The latest enhancements to the Bloomberg Government include:
Bill Tracking, which enables users to monitor change and follow activities related to legislation across all 50 states andWashington, D.C.
Heatmaps, which visualize legislation being considered across the country to identify opportunities and threats to policy initiatives.
Session Timeline,which delivers up-to-date legislative and committee calendars for all 50 states, making it easier to keep track of which chambers are in and out of session.
"Bloomberg Government's enhancements make searching state legislation very intuitive," said Research Specialist Meredith Heaps of Nelson Mullin. "Simple tabs and dedicated search boxes make it easy to find targeted information. I also love the legislative timeline at the top of each bill - the visual data representation makes it easy to determine key stages and status."
"State-focused policy professionals turn to Bloomberg Government to easily track and visualize issues across multiple jurisdictions so they can quickly engage the appropriate legislators on the key issues that matter to them," said Arielle Elliott, president of Bloomberg Government. "We're committed to continually enhancing our platform to provide our clients the most timely and actionable data and content to help make sense of - and react to - legislative developments.
For more information or to request a demo of Bloomberg Government, please visithttps://aboutbgov.com/9N3.
About Bloomberg Government
Bloomberg Government is a premium, subscription-based service that provides comprehensive information and analytics for professionals who interact with – or are affected by – the government. Delivering news, analytics, and data-driven decision tools, Bloomberg Government's digital workspace gives an intelligent edge to government affairs and contracting professionals. For more information or a demo, visit Bloomberg Government.
Read More
Emerging Technology, Government Business
Globenewswire | July 04, 2023
The Government of Canada has announced its intent to lead the fight against cancer at home and around the world with funding announced today that will support the development of a medical isotope ecosystem in Canada. The partnership includes Indigenous communities, Ontario’s nuclear industry, and leading research facilities, academics, and firms working to commercialize novel therapies.
As part of the funding announced today at the Bruce Power Visitors’ Centre, the Saugeen Ojibway Nation (SON) will take the next step in their partnership with Bruce Power to jointly produce, advance and market new isotopes in support of the global fight against cancer, while also working together to create new economic opportunities within the SON territory.
This funding will ultimately enable a pan-Canadian consortium – the Canadian Medical Isotope Ecosystem (CMIE) – to advance and accelerate the development of the next generation of novel medical isotopes and technologies. The CMIE will position Canada as a leader across all stages of the isotope production cycle, most importantly to ensure cancer patients and health care professionals have access to the critical isotopes they need, when they need them.
“Canada is a world leader in medical isotope research and production, and Bruce Power is proud to be among the innovative companies that places Canada at the forefront of nuclear medicine,” said Mike Rencheck, Bruce Power’s President and CEO. “We are honoured to partner with the Saugeen Ojibway Nation to market isotope production and thank the federal government for its support in leveraging this historic opportunity, while creating sustainable economic benefits within the SON territory.”
The Hon. François-Philippe Champagne, Minister of Innovation, Science and Industry, advanced the funding to support projects that strengthen Canada’s leadership position in research, development and production of medical isotopes and pharmaceuticals.
“Our government is proud to partner in the creation of the Canadian Medical Isotope Ecosystem, which includes support for the SON First Nations communities’ partnership with Bruce Power to innovate in the fight against cancer,” said Minister Champagne. “The pandemic has shown us how important it is to have strong domestic production of pharmaceuticals, and we are delivering on our commitment to providing Canadians with the best therapies they need to care for their health. With this investment, we are making our country a major player in the global biomanufacturing and life sciences industry while creating good jobs for Canadians and stimulating the local economy.”
Pam Damoff, Parliamentary Secretary to the Minister of Public Safety and the Member of Parliament for Oakville North-Burlington, has been a strong advocate for Canada’s medical isotope sector, and announced the funding on behalf of Minister Champagne at today’s event.
“With this investment in the creation of the Canadian Medical Isotope Ecosystem, the Government of Canada is taking another major step towards building resiliency in our domestic medical production capabilities, which will help to ensure the health and safety of Canadians in the event of any potential future global supply chain disruptions,” said Damoff. “This investment will not only grow the economy, as the Ecosystem is expected to attract over $75 million in investment, and create or maintain over 600 highly skilled, well-paying jobs, but also contribute to economic reconciliation with the Saugeen Ojibway Nation.”
Bruce Power partnered with the SON in 2019 in an historic collaboration for the marketing of current and new isotopes produced through the first-of-a-kind Isotope Production System (IPS) that was installed at Bruce Power in 2022. The partnership, named Gamzook’aamin aakoziwin, which translates to ‘We are Teaming Up to Fight the Sickness,’ includes a revenue-sharing program that provides a direct benefit to the community.
“Today marks another important milestone in the Gamzook’aamin Aakoziwin partnership between Bruce Power and the Saugeen Ojibway Nation,” said Chief Veronica Smith, Chippewas of Nawash Unceded First Nation. “By working together, patients around the world have access to cancer-fighting treatments made possible through medical isotope production.”
“We are proud to be part of this innovative project, which will deliver benefits beyond the local community, to people across the world in the global fight against cancer,” said Chief Conrad Ritchie, Chippewas of Saugeen First Nation.
The Made-in-Ontario IPS, designed and installed by Isogen (a joint venture between Framatome and Kinectrics) at Bruce Power, irradiates ytterbium-176 to produce lutetium-177, which is then transported to ITM’s manufacturing facility in Germany for processing of pharmaceutical-grade, non-carrier-added lutetium-177 (n.c.a. lutetium-177) and used in various clinical and commercial radiopharmaceutical cancer treatments.
“With commercial production of lutetium-177 well underway at Bruce Power, physicians and their patients worldwide now have access to a new, dependable, large-scale supply of lutetium-177 for their cancer treatments,” said John D’Angelo, Chair, Isogen Corp.
The funding announcement was made possible through Innovation, Science and Economic Development’s Strategic Innovation Fund, which provides major investments in innovative projects that will help grow Canada’s economy for the well-being of all Canadians. The investment will help develop Canadian technologies and support advancements in Canada’s medical isotope industry, supporting projects at Bruce Power, TRIUMF, Centre for Probe Development and Commercialization, McMaster Nuclear Reactor, Canadian Nuclear Laboratories and BWXT Medical.
About Bruce Power
Bruce Power is an electricity company based in Bruce County, Ontario. We are powered by our people. Our 4,200 employees are the foundation of our accomplishments and are proud of the role they play in safely delivering clean, reliable nuclear power to families and businesses across the province and life-saving medical isotopes around the world. Bruce Power has worked hard to build strong roots in Ontario and is committed to protecting the environment and supporting the communities in which we live. Formed in 2001, Bruce Power is a Canadian-owned partnership of TC Energy, OMERS, the Power Workers’ Union and The Society of United Professionals.
Read More